BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.71B |
| 2 |
Alibaba
BABA
|
+$2.19B |
| 3 |
Truist Financial
TFC
|
+$2.16B |
| 4 |
iShares MBS ETF
MBB
|
+$841M |
| 5 |
ServiceNow
NOW
|
+$829M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$5.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$2.34B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$983M |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
+$684M |
| 5 |
Apple
AAPL
|
+$623M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Financials | 14.42% |
| 3 | Healthcare | 13.59% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MLVF
3326
DELISTED
Malvern Bancorp, Inc.
MLVF
| $8.35M | ﹤0.01% |
361,553
+2,824
| +0.8% | +$63.9K |
|
|
USX
3327
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $8.33M | ﹤0.01% |
1,655,529
+105,510
| +7% | +$514K |
|
|
ESTE
3328
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $8.32M | ﹤0.01% |
1,314,395
+78,823
| +6% | +$371K |
|
3329
Franklin Financial Services
FRAF
$280M
| $8.32M | ﹤0.01% |
215,023
+5,877
| +3% | +$214K |
|
|
MFNC
3330
DELISTED
Mackinac Financial Corporation
MFNC
| $8.3M | ﹤0.01% |
475,430
+8,639
| +2% | +$137K |
|
3331
BBVA Argentina
BBAR
$3.49B
| $8.27M | ﹤0.01% |
1,485,452
-1,688,393
| -53% | -$6.97M |
|
3332
Senseonics Holdings Inc
SENS
$366M
| $8.27M | ﹤0.01% |
451,405
+73,148
| +19% | +$1.44M |
|
|
SDRL
3333
DELISTED
Seadrill Limited Common Stock
SDRL
| $8.26M | ﹤0.01% |
3,253,056
-1,226
| -0% | -$2.03K |
|
3334
Hercules Capital
HTGC
$3.23B
| $8.17M | ﹤0.01% |
582,994
+22,008
| +4% | +$306K |
|
3335
Abeona Therapeutics
ABEO
$413M
| $8.13M | ﹤0.01% |
99,490
-1,504
| -1% | -$106K |
|
3336
Celsius Holdings
CELH
$7.03B
| $8.13M | ﹤0.01% |
5,048,739
+736,470
| +17% | +$978K |
|
3337
Chemung Financial Corp
CHMG
$392M
| $8.12M | ﹤0.01% |
191,032
+613
| +0.3% | +$26.8K |
|
|
K
3338
PUT
DELISTED
Kellanova
K
| $8.09M | ﹤0.01% |
124,605
| – | – |
|
3339
Medallion Financial
MFIN
$250M
| $8.07M | ﹤0.01% |
1,109,773
+5,906
| +0.5% | +$38.7K |
|
|
CMRX
3340
DELISTED
Chimerix, Inc.
CMRX
| $7.96M | ﹤0.01% |
3,922,938
+356,794
| +10% | +$658K |
|
|
FNCB
3341
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $7.96M | ﹤0.01% |
941,223
+8,088
| +0.9% | +$63.6K |
|
3342
Cytosorbents Corp
CTSO
$22.6M
| $7.93M | ﹤0.01% |
2,059,602
-577
| -0% | -$2.52K |
|
|
MPX
3343
DELISTED
Marine Products Corp
MPX
| $7.92M | ﹤0.01% |
550,065
+13,803
| +3% | +$200K |
|
3344
Mustang Bio
MBIO
$4.55M
| $7.92M | ﹤0.01% |
2,587
+210
| +9% | +$481K |
|
|
TCFC
3345
DELISTED
The Community Financial Corporation Common Stock
TCFC
| $7.92M | ﹤0.01% |
222,488
-117
| -0.1% | -$3.96K |
|
|
PROS
3346
DELISTED
ProSight Global, Inc.
PROS
| $7.91M | ﹤0.01% |
490,435
-102,598
| -17% | -$1.73M |
|
|
OTRK
3347
DELISTED
Ontrak
OTRK
| $7.91M | ﹤0.01% |
5,386
+114
| +2% | +$157K |
|
3348
Peoples Bancorp of North Carolina
PEBK
$229M
| $7.89M | ﹤0.01% |
240,220
+603
| +0.3% | +$18.4K |
|
|
MRNS
3349
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $7.89M | ﹤0.01% |
912,738
+32,788
| +4% | +$184K |
|
3350
Twin Disc
TWIN
$348M
| $7.86M | ﹤0.01% |
713,405
+1,888
| +0.3% | +$19.7K |
|
Similar funds
BlackRock's Q4 2019 Portfolio in Review
As of Q4 2019, BlackRock held 5,193 positions worth $2.61T, up 9.5% from $2.38T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock's Q4 2019 filing shows 167 new, 2,887 increased, 1,450 reduced and 161 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M. The largest sale was Celgene Corp, an estimated $5.15B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M.
- BlackRock added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.71B increase.
- BlackRock's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $983M.
- BlackRock fully exited Celgene Corp in Q4 2019, selling an estimated $5.15B.
- BlackRock's ten largest holdings make up 15% of its $2.61T portfolio in Q4 2019.
- BlackRock opened 167 new positions and closed 161 in Q4 2019.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $2.61T.
Based on BlackRock's 13F filing for Q4 2019, filed 13 Feb 2020.